Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03260842 · ClinicalTrials.gov registry record

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

A clinical trial of Pancreatic Cyst and Pancreas Disease, sponsored by Stanford University.

Recruiting
Registry status
500
Enrollment target
1
Study location

NCT03260842 is a study of Pancreatic Cyst and Pancreas Disease that is actively recruiting participants, run by Stanford University. The registered enrollment target is 500 participants, roughly in line with the 522-participant average among 18 other Pancreatic Cyst trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03260842, a study of Pancreatic Cyst and Pancreas Disease, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

Bio-repository to collect bio-specimens from patients with 1) pancreatic cysts and 2) patients at high risk, defined by family history and/or genetic mutations, for pancreatic cancer.

Interventions

  • DIAGNOSTIC_TEST Bio-Specimen Collection

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2017-09-01
Est. Completion 2030-04-30

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03260842

The ClinicalTrials.gov registry entry for NCT03260842 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 522-participant average among 18 other Pancreatic Cyst trials with a reported enrollment target. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pancreatic Cyst appearing as the primary indexed condition, and to 1 intervention - of which Bio-Specimen Collection is the first listed.

NCT03260842 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03260842 about?

NCT03260842 is a clinical study titled "Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer". Bio-repository to collect bio-specimens from patients with 1) pancreatic cysts and 2) patients at high risk, defined by family history and/or genetic mutations, for pancreatic cancer.

What is the current status of trial NCT03260842?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2017-09-01. Estimated completion is 2030-04-30.

What conditions does trial NCT03260842 study?

This clinical trial studies the following conditions: Pancreatic Cyst, Pancreas Disease.

What interventions are being tested in trial NCT03260842?

The interventions under investigation include: Bio-Specimen Collection (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03260842?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03260842 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pancreatic Cyst

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.